Immunic to participate in scientific and industry conferences in october

New york , oct. 4, 2022 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following scientific and industry conferences in october: october 8-11: 30th united european gastroenterology (ueg) week 2022. members of immunic's clinical team will attend this conference in vienna.
IMUX Ratings Summary
IMUX Quant Ranking